Condition
Gastro-oesophageal Reflux Disease
Total Trials
7
Recruiting
2
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
43%
3 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
P 2 (1)
P 3 (1)
P 4 (2)
Trial Status
Completed3
Not Yet Recruiting2
Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT07093359Phase 3RecruitingPrimary
LINX vs Fundoplication
NCT06664008Phase 4Not Yet RecruitingPrimary
The Effect of Probiotic and Zinc Supplementation in Patients With Gastroesophageal Reflux Disease
NCT06615856Not Yet Recruiting
The Influence of Concomitant Irritable Bowel Syndrome on Gastro-Oesophageal Reflux Disease Symptoms and Severity.
NCT06317675Phase 2RecruitingPrimary
Osteopathic Manipulative Treatment for Gastro-oesophageal Reflux Disease
NCT03793556Not ApplicableCompletedPrimary
Evaluation of GERDOFF Efficacy in Combination With Proton Pump Inhibitor
NCT01507298CompletedPrimary
Physical Activity and Gastrointestinal Investigations
NCT00384592Phase 4CompletedPrimary
PPI Sequencing Study
Showing all 7 trials